Quick Answer
CG Oncology, Inc. reported Total Assets of $791.59 million for fiscal year 2025.
CG Oncology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $791.59M | +4.9% |
| 2024 | $754.80M | +278.7% |
| 2023 | $199.30M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $729.91M | +32.1% | +4.1% |
| June 30, 2025 | $701.45M | +24.3% | -3.7% |
| March 31, 2025 | $728.18M | +25.7% | -3.5% |
| December 31, 2024 | $754.80M | +278.7% | +36.6% |
| September 30, 2024 | $552.47M | — | -2.1% |
| June 30, 2024 | $564.33M | — | -2.6% |
| March 31, 2024 | $579.11M | — | +190.6% |
| December 31, 2023 | $199.30M | — | — |
- CG Oncology, Inc. showed an increase of +4.9% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, CG Oncology, Inc.’s total assets has grown by 297.2% (from $199.30 million to $791.59 million).
- The most recent figure is from CG Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: